Lazard Asset Management »

Neuropace shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $40k 3.9k 10.18

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Alphabet Inc A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Norfolk Souther Common Stock (NSC)
Visa Common Stock (V)
Accenture Common Stock (ACN)
Intercontinen Common Stock (ICE)
Unitedhealth Gr Common Stock (UNH)
Aon Plc/ireland Common Stock (AON)
Bank Of America Common Stock (BAC)
Thermo Fisher Common Stock (TMO)
Analog Devices Common Stock (ADI)
Mcdonalds Corp Common Stock (MCD)
John & John Common Stock (JNJ)
Amer Express Common Stock (AXP)

View all positions for Lazard Asset Management

Top funds holding Neuropace

OrbiMed Advisors
Soleus Capital Management
Nantahala Capital Management
Kent Lake Capital
Vanguard Group
Millennium Management
Jane Street
Citigroup
Bank of America Corporation
Balyasny Asset Management
683 Capital Management
Citadel Advisors
Laurion Capital Management
Man Group
Townsquare Capital

View all funds holding Neuropace